Denton Pharma, Inc.

FDA Drug Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 70934-309-30); b) 60 count (NDC 70934-309-60); c) 90 count (70934-309-90); d) 120 count (NDC 70934-309-98) bottles, Rx On

October 8, 2020 Denton Pharma, Inc. a) 684; b) 432; c) 3668; d) 2029 bottles units

FDA Drug Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30

October 8, 2020 Denton Pharma, Inc. N/A units

FDA Drug Class II Terminated

Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-cou

December 20, 2019 Denton Pharma, Inc. 1,341 bottles units

FDA Drug Class II Terminated

Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131

December 20, 2019 Denton Pharma, Inc. 467 bottles units